$13.27
Today
as of Jul 22, 16:26 ET
Last 30 days
Recent Press Releases & News
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
XRAY: What does Argus have to say about XRAY?
BMO Capital Initiates DENTSPLY SIRONA at Market Perform With $12 Price Target
Overview
52-week range
$9.41
$17
50% of range
Avg surprise (last 3)
+16.2%
Avg reaction (last 2)
+8.9%
100% positive
Latest IV / EM
32%
EM ±7.3% · $13 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 5, 2026 | Mar/2026 | $0.27 | $0.28 | -3.6% | -37.2% | +1.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-2.14 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.52 | $0.50 | +4.0% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.43 | $0.29 | +48.3% | — | +16.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.46 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.02 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.09 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.25 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.40 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | OTHER | $0.36 | $0.52 | -30.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $453M | — | $463M | $446M | $413M | — | $456M | $473M |
| Gross profit | $427M | — | $441M | $490M | $466M | — | $495M | $511M |
| Operating income | $-35M | — | $-218M | $-128M | $63M | — | $-462M | $50M |
| Net income | $-10M | — | $-427M | $-45M | $20M | — | $-494M | $-4M |
| EPS (diluted) | $-0.05 | — | $-2.14 | $-0.22 | $0.10 | — | $-2.46 | $-0.02 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $190M | $326M | $363M | $359M | $398M | $272M | $296M | $279M |
| Inventory | $659M | $642M | $686M | $675M | $612M | $564M | $619M | $608M |
| Total current assets | $1.84B | $2.02B | $2.07B | $1.97B | $1.98B | $1.75B | $1.92B | $1.76B |
| Total assets | $5.23B | $5.43B | $5.65B | $6.07B | $6.05B | $5.75B | $6.63B | $6.90B |
| Long-term debt | $2.01B | $2.02B | $2.02B | $2.22B | $1.59B | $1.59B | $1.79B | $1.74B |
| Total liabilities | $3.91B | $4.09B | $4.17B | $4.11B | $4.04B | $3.81B | $4.14B | $3.83B |
| Total equity | $1.32B | $1.34B | $1.48B | $1.96B | $2.01B | $1.94B | $2.49B | $3.06B |